# The REVIVE Pivotal Study

> **NCT07361653** · NA · NOT_YET_RECRUITING · sponsor: **Ryme Medical, Inc.** · enrollment: 300 (estimated)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)
- COPD Exacerbations
- COPD Patients
- COPD Acute Exacerbation
- COPD
- Lung Disease Airways
- Lung Disease, Chronic Obstructive

## Interventions

- **DEVICE:** Ryme TLD
- **DEVICE:** Sham Control

## Key facts

- **NCT ID:** NCT07361653
- **Lead sponsor:** Ryme Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07361653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07361653, "The REVIVE Pivotal Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07361653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*